These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29860519)

  • 1. High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
    Negredo E; Langohr K; Bonjoch A; Pérez-Alvárez N; Estany C; Puig J; Rosales J; Echeverría P; Clotet B; Gómez G
    J Antimicrob Chemother; 2018 Sep; 73(9):2452-2459. PubMed ID: 29860519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
    Bonjoch A; Figueras M; Estany C; Perez-Alvarez N; Rosales J; del Rio L; di Gregorio S; Puig J; Gómez G; Clotet B; Negredo E;
    AIDS; 2010 Nov; 24(18):2827-33. PubMed ID: 21045635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men.
    Erlandson KM; Lake JE; Sim M; Falutz J; Prado CM; Domingues da Silva AR; Brown TT; Guaraldi G
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):288-294. PubMed ID: 29140875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study.
    Komatsu A; Ikeda A; Kikuchi A; Minami C; Tan M; Matsushita S
    Drug Saf; 2018 Sep; 41(9):843-848. PubMed ID: 29623648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J; García R; Lozano F; Macías J; García-García JA; Mira JA; Corzo JE; Gómez-Mateos J; Rueda A; Sánchez-Burson J; Pineda JA
    HIV Clin Trials; 2003; 4(5):337-46. PubMed ID: 14583850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
    Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan.
    Negredo E; Bonjoch A; Gómez-Mateu M; Estany C; Puig J; Perez-Alvarez N; Rosales J; di Gregorio S; del Rio L; Gómez G; Clotet B
    PLoS One; 2012; 7(10):e46031. PubMed ID: 23056229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study.
    White VanGompel EC; Franks P; Robbins JA; Fenton JJ
    J Gen Intern Med; 2017 Oct; 32(10):1090-1096. PubMed ID: 28634907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
    Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
    Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.
    McComsey GA; Lupo S; Parks D; Poggio MC; De Wet J; Kahl LP; Angelis K; Wynne B; Vandermeulen K; Gartland M; Cupo M; Aboud M;
    AIDS; 2018 Feb; 32(4):477-485. PubMed ID: 29239893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.
    Tebas P; Powderly WG; Claxton S; Marin D; Tantisiriwat W; Teitelbaum SL; Yarasheski KE
    AIDS; 2000 Mar; 14(4):F63-7. PubMed ID: 10770534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors associated with osteopenia and osteoporosis in women undergoing bone mineral density test].
    Veiga Silva AC; da Rosa MI; Fernandes B; Lumertz S; Diniz RM; dos Reis Damiani ME
    Rev Bras Reumatol; 2015; 55(3):223-8. PubMed ID: 25440700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis and low bone mineral density (osteopenia) in rural and remote Queensland.
    Macgregor CB; Meerkin JD; Alley SJ; Vandelanotte C; Reaburn PJ
    Aust J Rural Health; 2018 Oct; 26(5):369-374. PubMed ID: 30303279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and association of osteoarthritis with fracture risk.
    Chan MY; Center JR; Eisman JA; Nguyen TV
    Osteoarthritis Cartilage; 2014 Sep; 22(9):1251-8. PubMed ID: 25042553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
    Gafni RI; Hazra R; Reynolds JC; Maldarelli F; Tullio AN; DeCarlo E; Worrell CJ; Flaherty JF; Yale K; Kearney BP; Zeichner SL
    Pediatrics; 2006 Sep; 118(3):e711-8. PubMed ID: 16923923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of HIV to bone mineral density].
    Wessman M; Weis N; Katzenstein TL; Lebech AM; Thorsteinsson K; Hansen AE; Jensen JB
    Ugeskr Laeger; 2017 Sep; 179(36):. PubMed ID: 28874254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.